Taste sensitivity to 6-n-propylthiouracil is associated with endocannabinoid plasma levels in normal-weight individuals

Nutrition

Volumn 29, Issue 3, 2013, Pages 531-536

  Tomassini Barbarossa, Iole ^a   Carta, Gianfranca ^a   Murru, Elisabetta ^a   Melis, Melania ^a   Zonza, Andrea ^a   Vacca, Claudia ^a   Muroni, Patrizia ^a   Di Marzo, Vincenzo ^b   Banni, Sebastiano ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b CNR   (Italy)

Author keywords

6 n Propylthiouracil taste sensitivity; Control of eating behavior; Endocannabinoids; Normal weight subjects; Oleoylethanolamide

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 6 N PROPYLTHIOURACIL; AMIDE; ANANDAMIDE; ENDOCANNABINOID; OLEYLETHANOLAMIDE; OMEGA 3 FATTY ACID; PALMIDROL; UNCLASSIFIED DRUG; URACIL;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; ENERGY BALANCE; EXECUTIVE FUNCTION; FEEDING BEHAVIOR; FEMALE; HUMAN; HUMAN EXPERIMENT; HUNGER; MALE; NORMAL HUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PERCEPTION; PRIORITY JOURNAL; SATIETY; SCORING SYSTEM; SENSITIVITY ANALYSIS; SEX DIFFERENCE; STIMULUS RESPONSE; TASTE ACUITY;

ADULT; BODY MASS INDEX; BODY WEIGHT; COGNITION; ENDOCANNABINOIDS; ENERGY INTAKE; FEEDING BEHAVIOR; FEMALE; HUMANS; HUNGER; MALE; SATIATION; TASTE; URACIL;

EID: 84873541352     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.09.018     Document Type: Article

References (57)

1. Flegal K.M., Carroll M.D., Kit B.K., Ogden C.L. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012, 307:491-497.
2. Tepper B.J., Neilland M., Ullrich N.V., Koelliker Y., Belzer L.M. Greater energy intake from a buffet meal in lean, young women is associated with the 6-n-propylthiouracil (PROP) non-taster phenotype. Appetite 2011, 56:104-110.
3. Donaldson L.F., Bennett L., Baic S., Melichar J.K. Taste and weight: is there a link?. Am J Clin Nutr 2009, 90:800S-803S.
4. Monneuse M.O., Rigal N., Frelut M.L., Hladik C.M., Simmen B., Pasquet P. Taste acuity of obese adolescents and changes in food neophobia and food preferences during a weight reduction session. Appetite 2008, 50:302-307.
5. Tepper B.J. Nutritional implications of genetic taste variation: the role of PROP sensitivity and other taste phenotypes. Annu Rev Nutr 2008, 28:367-388.
6. Tepper B.J., White E.A., Koelliker Y., Lanzara C., d'Adamo P., Gasparini P. Genetic variation in taste sensitivity to 6-n-propylthiouracil and its relationship to taste perception and food selection. Ann N Y Acad Sci 2009, 1170:126-139.
7. Bartoshuk L.M. The biological basis of food perception and acceptance. Food Qual Prefer 1993, 41:21-32.
8. Bartoshuk L.M., Duffy V.B., Miller I.J. PTC/PROP tasting: anatomy, psychophysics, and sex effects. Physiol Behav 1994, 56:1165-1171.
9. Bufe B., Breslin P.A., Kuhn C., Reed D.R., Tharp C.D., Slack J.P., et al. The molecular basis of individual differences in phenylthiocarbamide and propylthiouracil bitterness perception. Curr Biol 2005, 15:322-327.
10. Kim U.K., Jorgenson E., Coon H., Leppert M., Risch N., Drayna D. Positional cloning of the human quantitative trait locus underlying taste sensitivity to phenylthiocarbamide. Science 2003, 299:1221-1225.
11. Essick G.K., Chopra A., Guest S., McGlone F. Lingual tactile acuity, taste perception, and the density and diameter of fungiform papillae in female subjects. Physiol Behav 2003, 80:289-302.
12. Padiglia A., Zonza A., Atzori E., Chillotti C., Calo C., Tepper B.J., et al. Sensitivity to 6-n-propylthiouracil is associated with gustin (carbonic anhydrase VI) gene polymorphism, salivary zinc, and body mass index in humans. Am J Clin Nutr 2010, 92:539-545.
13. Duffy V.B., Bartoshuk L.M. Food acceptance and genetic variation in taste. J Am Diet Assoc 2000, 100:647-655.
14. Hayes J.E., Duffy V.B. Revisiting sucrose-fat mixtures: sweetness and creaminess vary with phenotypic markers of oral sensation. Chem Senses 2007, 32:225-236.
15. Keller K.L., Steinmann L., Nurse R.J., Tepper B.J. Genetic taste sensitivity to 6-n-propylthiouracil influences food preference and reported intake in preschool children. Appetite 2002, 38:3-12.
16. Tepper B.J., Nurse R.J. PROP taster status is related to the perception and preference for fat. Ann N Y Acad Sci 1998, 855:802-804.
17. Duffy V.B., Davidson A.C., Kidd J.R., Kidd K.K., Speed W.C., Pakstis A.J., et al. Bitter receptor gene (TAS2R38), 6-n-propylthiouracil (PROP) bitterness and alcohol intake. Alcohol Clin Exp Res 2004, 28:1629-1637.
18. Hayes J.E., Duffy V.B. Oral sensory phenotype identifies level of sugar and fat required for maximal liking. Physiol Behav 2008, 95:77-87.
19. Goldstein G.L., Daun H., Tepper B.J. Adiposity in middle-aged women is associated with genetic taste blindness to 6-n-propylthiouracil. Obes Res 2005, 13:1017-1023.
20. Tepper B.J. Does genetic taste sensitivity to PROP influence food preferences and body weight?. Appetite 1999, 32:422.
21. Tepper B.J., Ullrich N.V. Influence of genetic taste sensitivity to 6-n-propylthiouracil (PROP), dietary restraint and disinhibition on body mass index in middle-aged women. Physiol Behav 2002, 75:305-312.
22. Drewnowski A., Henderson S.A., Cockroft J.E. Genetic sensitivity to 6-n-propylthiouracil has no influence on dietary patterns, body mass indexes, or plasma lipid profiles of women. J Am Diet Assoc 2007, 107:1340-1348.
23. Kaminski L.C., Henderson S.A., Drewnowski A. Young women's food preferences and taste responsiveness to 6-n-propylthiouracil (PROP). Physiol Behav 2000, 68:691-697.
24. Timpson N.J., Christensen M., Lawlor D.A., Gaunt T.R., Day I.N., Ebrahim S., et al. TAS2R38 (phenylthiocarbamide) haplotypes, coronary heart disease traits, and eating behavior in the British Women's Heart and Health Study. Am J Clin Nutr 2005, 81:1005-1011.
25. Yackinous C., Guinard J.X. Relation between PROP taster status and fat perception, touch, and olfaction. Physiol Behav 2001, 72:427-437.
26. Yackinous C.A., Guinard J.X. Relation between PROP (6-n-propylthiouracil) taster status, taste anatomy and dietary intake measures for young men and women. Appetite 2002, 38:201-209.
27. Tepper B.J., Koelliker Y., Zhao L., Ullrich N.V., Lanzara C., d'Adamo P., et al. Variation in the bitter-taste receptor gene TAS2R38, and adiposity in a genetically isolated population in Southern Italy. Obesity 2008, 16:2289-2295.
28. Di Marzo V., Ligresti A., Cristino L. The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation. Int J Obes 2009, 33:S18-S24.
29. Di Marzo V. Endocannabinoids: an appetite for fat. Proc Natl Acad Sci U S A 2011, 108:12567-12568.
30. DiPatrizio N.V., Astarita G., Schwartz G., Li X., Piomelli D. Endocannabinoid signal in the gut controls dietary fat intake. Proc Natl Acad Sci U S A 2011, 108:12904-12908.
31. Monteleone P., Piscitelli F., Scognamiglio P., Monteleone A.M., Canestrelli B., Di Marzo V., et al. Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study. J Clin Endocrinol Metab 2012, 97:E917-E924.
32. Di Marzo V., Cote M., Matias I., Lemieux I., Arsenault B.J., Cartier A., et al. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. Diabetologia 2009, 52:213-217.
33. Rankin K.M., Godinot N., Christensen C.M., Tepper B.J., Kirkmeyer S.V. Assessment of different methods for 6-n-propylthiouracil status classification. Genetic variation in taste sensitivity 2004, 63-88. Marcel Dekker, New York. J. Prescott, B.J. Tepper (Eds.).
34. Tepper B.J., Christensen C.M., Cao J. Development of brief methods to classify individuals by PROP taster status. Physiol Behav 2001, 73:571-577.
35. Green B.G., Shaffer G.S., Gilmore M.M. Derivation and evaluation of a semantic scale of oral sensation magnitude with apparent ratio properties. Chem Senses 1993, 18:1017-1023.
36. Glanville E.V., Kaplan A.R. The menstrual cycle and sensitivity of taste perception. Am J Obstet Gynecol 1965, 92:189-194.
37. Stunkard A.J., Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985, 29:71-83.
38. Folch J., Lees M., Sloane-Stanley G.H. A simple method for the isolation and purification of total lipid from animal tissues. J Biol Chem 1957, 226:497-509.
39. Banni S., Carta G., Contini M.S., Angioni E., Deiana M., Dessi M.A., et al. Characterization of conjugated diene fatty acids in milk, dairy products, and lamb tissues. J Nutr Biochem 1996, 7:150-155.
40. Melis M.P., Angioni E., Carta G., Murru E., Scanu P., Spada S., et al. Characterization of conjugated linoleic acid and its metabolites by RP-HPLC with diode array detector. Eur J Lipid Sci Technol 2001, 103:617-621.
41. Piscitelli F., Carta G., Bisogno T., Murru E., Cordeddu L., Berge K., et al. Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice. Nutr Metab 2011, 8:51.
42. Stark K.D. The percentage of n-3 highly unsaturated fatty acids in total HUFA as a biomarker for omega-3 fatty acid status in tissues. Lipids 2008, 43:45-53.
43. Fischer R., Griffin F., Rockey M.A. Gustatory chemoreception in man: multidisciplinary aspects and perspectives. Perspect Biol Med 1966, 9:549-577.
44. Sausenthaler S., Rzehak P., Wichmann H.E., Heinrich J. Lack of relation between bitter taste receptor TAS2R38 and BMI in adults. Obesity 2009, 17:937-938.
45. Bryant E.J., King N.A., Blundell J.E. Disinhibition: its effects on appetite and weight regulation. Obes Rev 2008, 9:409-419.
46. Bluher M., Engeli S., Kloting N., Berndt J., Fasshauer M., Batkai S., et al. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 2006, 55:3053-3060.
47. Cote M., Matias I., Lemieux I., Petrosino S., Almeras N., Despres J.P., et al. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Int J Obes 2007, 31:692-699.
48. Monteleone P., Matias I., Martiadis V., De Petrocellis L., Maj M., Di Marzo V. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. Neuropsychopharmacology 2005, 30:1216-1221.
49. Hansen H.S., Diep T.A. N-acylethanolamines, anandamide and food intake. Biochem Pharmacol 2009, 78:553-560.
50. Banni S., Di Marzo V. Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood. Mol Nutr Food Res 2010, 54:82-92.
51. Pintus S, Murru E, Carta G, Cordeddu L, Batetta B, Accossu S, et al. Sheep cheese naturally enriched in alpha-linolenic, conjugated linoleic and vaccenic acids improves the lipid profile and reduces anandamide in the plasma of hypercholesterolaemic subjects. Br J Nutr.
52. Lands W.E., Libelt B., Morris A., Kramer N.C., Prewitt T.E., Bowen P., et al. Maintenance of lower proportions of (n-6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n-3) fatty acids. Biochim Biophys Acta 1992, 1180:147-162.
53. Chen C.Y., Fujimiya M., Laviano A., Chang F.Y., Lin H.C., Lee S.D. Modulation of ingestive behavior and gastrointestinal motility by ghrelin in diabetic animals and humans. J Chin Med Assoc 2010, 73:225-229.
54. Alvheim A.R., Malde M.K., Osei-Hyiaman D., Hong Lin Y., Pawlosky R., Madsen L., et al. Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. Obesity 2012, 20:1984-1994.
55. Artmann A., Petersen G., Hellgren L.I., Boberg J., Skonberg C., Nellemann C., et al. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta 2008, 1781:200-212.
56. Banni S., Carta G., Murru E., Cordeddu L., Giordano E., Sirigu A.R., et al. Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects. Nutr Metab 2011, 8:7.
57. Batetta B., Griinari M., Carta G., Murru E., Ligresti A., Cordeddu L., et al. Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J Nutr 2009, 139:1495-1501.